Status:
COMPLETED
Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Uveitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Uveitis, the inflammation of the uvea, is a rare disease with an incidence of 52/100,000 inhabitants per year and a prevalence of 115 / 100,000 inhabitants per year. The causes of uveitis are num...
Eligibility Criteria
Inclusion
- Uveitis
- Patient consulting one of the study's sites
- Age \> 18 years old
- Affiliation to the French national health insurance program
- Patient agreeing to participate in the study
Exclusion
- Positive HIV serology
- Postsurgical or posttraumatic uveitis or endophthalmitis
- Toxoplasmic uveitis
- Pathology likely to be the cause of the known uveitis
- Ophthalmic entities only diagnosed by the ophthalmic examination
- Age \< 18 years old
- Patient under law protection or guardianship
- Pregnant women or those planning to be pregnant during the study
- Severe uveitis (VA \< 20/200) with retinal vascularitis requiring an emergency treatment and assessment.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
905 Patients enrolled
Trial Details
Trial ID
NCT01162070
Start Date
June 1 2010
End Date
July 1 2014
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Médecine Interne, Hospices Civils de Lyon (HCL)-Hôpital de la Croix Rousse
Lyon, France, 69004